UAB’s Mark Dransfield has been elected to the American Society for Clinical Investigation, an honor society for physician-scientists who have made significant contributions to better understanding of human disease.
The award recognizes a significant paper by Cui in Cell Death and Differentiation.
UAB has created the only comprehensive interventional pulmonary medicine program in Alabama to better diagnose and treat lung and chest diseases.
Abnormal antibody production that allows inflammation leading to AIDS is detected by analysis of antibodies in gut fluid of HIV-1-infected people.
UAB’s innovative Patient Care Connect Program utilizes lay navigation and provides a cost-effective new model for cancer care delivery.
In another example of precision medicine, UAB researchers have used IPF patients own lung tissue to create models to determine the most effective medication for that patient.
Five faculty members in the School of Medicine have been named the 2016 class of James A. Pittman Jr., M.D., Scholars, a program organized to recognize the contributions of junior faculty and support the retention of highly competitive scientists and physician-scientists.
The Diversity Day events on Feb. 3 will begin with Diversity Grand Rounds, featuring John Ruffin, Ph.D., the founding director of the National Institute on Minority Health and Health Disparities, at noon in the Margaret Cameron Spain Auditorium.
Cardiac muscle patches in this proof-of-concept research may represent an important step toward the clinical use of 3-D-printing technology, as researchers have grown heart tissue by seeding a mix of human cells onto a 1-micron-resolution scaffold made with a 3-D printer.
UAB and VICIS have each made major strides in developing next generation football helmets in response to the growing concussion crisis, and they have partnered to combine expertise and intellectual property to bring more effective helmets to the market.